Predicting survival in atrial fibrillation: results from SAGE-AF
Two-year survival was high. This model, if validated, could have major implications for treatment of patients with AF. Patients in the large group with no or one event are at very low risk of death (under 2%). The small group with high risk for further complications, including death, deserve reassessment to determine if this trajectory can be altered.
Authors
- Edith Mensah Otabil (ORCID: https://orcid.org/0000-0002-8926-8403)
- Catarina I. Kiefe (ORCID: https://orcid.org/0000-0001-8719-6963)
- Francis C. Dane (ORCID: https://orcid.org/0000-0002-4120-0565)
- Jordy Mehawej (ORCID: https://orcid.org/0000-0001-6877-6778)
- David C. Parish (ORCID: https://orcid.org/0000-0002-0971-0354)
- Carly N Beniek
Institutions
- Mercer University (US)
- University of Massachusetts Chan Medical School (US)
- Radford University (US)
Publication Details
- Journal
- Journal of Geriatric Cardiology
- Published
- 2025-03-01
- DOI
- https://doi.org/10.26599/1671-5411.2025.03.004
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00